ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

摘要:

In addition to the problems of dealing with multidrug-resistant bacteria, clinicians are now faced with multidrug-resistant fungi. Some 5-10 years ago, resistance of fungi to drugs was extremely rare, but now resistance to conventional antifungal agents has been reported, particularly in immunocompromised patients. This calls for immediate action. According to researchers at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) [New Orleans, US; September 1996], several measures are being taken. These include the short-term option of trying alternative treatment approaches, and the longer-term strategy of developing new antifungal agents that employ different mechanisms of action to those of currently available drugs.

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

摘要:

The costs of treating, and not appropriately treating, diabetes mellitus were discussed by researchers from Germany and the US at the 12th International Conference on Pharmacoepidemiology [Amsterdam, The Netherlands; August 1996]. Wolfgang Rathmann from the Diabetes Research Institute in Dusseldorf, Germany, showed that prescription drug use and costs are substantially higher for patients with diabetes mellitus than for those without the disease. Dr Kimberly Javor from Eli Lilly in the US reported that diabetic ketoacidosis accounts for $US1 out of every $US4 spent on medical care for patients with insulin-dependent diabetes mellitus (IDDM).

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS